Last 7 days
0.4%
Last 30 days
7.2%
Last 90 days
2.2%
Trailing 12 Months
-28.3%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-31 | Mandadi Tilak | sold (taxes) | -850,664 | 65.17 | -13,053 | evp, chief technology officer |
2023-08-31 | Shah Prem S | sold (taxes) | -228,616 | 65.17 | -3,508 | evp and co-president of retail |
2023-08-03 | Clark James David | sold | -1,930,000 | 74.9247 | -25,759 | svp, cont & chief acct officer |
2023-05-18 | DEPARLE NANCY ANN | acquired | 99,598 | 69.31 | 1,437 | - |
2023-05-18 | Finucane Anne A. | acquired | 99,598 | 69.31 | 1,437 | - |
2023-05-18 | MILLON JEAN PIERRE | acquired | 99,598 | 69.31 | 1,437 | - |
2023-05-18 | AGUIRRE FERNANDO | acquired | 92,113 | 69.31 | 1,329 | - |
2023-05-18 | Balser Jeffrey R. | acquired | 92,113 | 69.31 | 1,329 | - |
2023-05-03 | Lynch Karen S | bought | 976,567 | 69.7548 | 14,000 | president and ceo |
2023-04-01 | Lynch Karen S | sold (taxes) | -6,961,140 | 74.31 | -93,677 | president and ceo |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-21 | Baystate Wealth Management LLC | added | 22.26 | 54,530 | 451,769 | 0.04% |
2023-09-21 | Jefferies Group LLC | reduced | -58.47 | -385,624 | 287,921 | -% |
2023-09-21 | Halpern Financial, Inc. | unchanged | - | -430 | 5,738 | -% |
2023-09-20 | BARCLAYS PLC | added | 97.8 | 173,058,000 | 379,052,000 | 0.24% |
2023-09-18 | CAPE ANN SAVINGS BANK | added | 1.49 | -37,531 | 634,752 | 0.42% |
2023-09-14 | IMS Capital Management | added | 2.77 | -30,354 | 660,952 | 0.37% |
2023-09-12 | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | sold off | -100 | -16,719,800 | - | -% |
2023-09-12 | DCM Advisors, LLC | reduced | -38.16 | -2,069,060 | 2,803,150 | 1.20% |
2023-09-12 | Farther Finance Advisors, LLC | reduced | -5.07 | -52,071 | 393,770 | 0.09% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 26,912,400 | 26,912,400 | 1.42% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 8.94% | 117,533,372 | SC 13G/A | |
Feb 07, 2023 | blackrock inc. | 7.4% | 96,668,258 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 8.28% | 109,236,922 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.1% | 93,556,500 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.05% | 105,383,923 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 7.1% | 92,478,369 | SC 13G/A | |
Feb 12, 2020 | vanguard group inc | 8.05% | 104,808,202 | SC 13G/A | |
Feb 05, 2020 | blackrock inc. | 7.2% | 94,158,010 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 21, 2023 | 8-K | Current Report | |
Sep 11, 2023 | 8-K | Current Report | |
Sep 08, 2023 | 3 | Insider Trading | |
Sep 01, 2023 | 4 | Insider Trading | |
Sep 01, 2023 | 4 | Insider Trading | |
Aug 23, 2023 | 8-K | Current Report | |
Aug 17, 2023 | 8-K | Current Report | |
Aug 04, 2023 | 4 | Insider Trading | |
Aug 04, 2023 | 13F-HR | Fund Holdings Report | |
Aug 03, 2023 | 144 | Notice of Insider Sale Intent |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 473.0B | 348.5B | 3.40% | -1.54% | 22.41 | 1.36 | 13.69% | 15.63% |
CVS | 93.0B | 339.2B | 7.15% | -28.30% | 30.1 | 0.27 | 10.18% | -63.11% |
CI | 91.1B | 186.1B | 2.70% | 3.10% | 13.64 | 1.92 | 3.72% | 22.38% |
HUM | 65.7B | 98.7B | 2.62% | 0.03% | 23.41 | 0.71 | 10.45% | 7.48% |
CNC | 38.5B | 147.9B | 7.94% | -13.00% | 14.2 | 0.26 | 7.12% | 45.86% |
MID-CAP | ||||||||
HQY | 6.3B | 937.9M | 8.26% | -1.16% | 491.91 | 6.73 | 17.97% | 120.64% |
OPCH | 6.1B | 4.1B | -5.40% | 9.61% | 25.5 | 1.48 | 11.23% | 37.01% |
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
PDCO | 2.8B | 6.5B | -13.00% | 16.88% | 13.3 | 0.44 | 1.83% | 10.70% |
SMALL-CAP | ||||||||
RDNT | 1.9B | 1.5B | -12.60% | 56.43% | -148.05 | 1.25 | 12.20% | -155.34% |
ADUS | 1.4B | 999.1M | -5.28% | -6.03% | 26.12 | 1.41 | 10.42% | 21.37% |
BKD | 835.8M | 3.0B | 0.71% | -13.03% | -8.11 | 0.28 | 11.66% | -12.20% |
JYNT | 136.4M | 107.9M | -0.31% | -40.30% | 37.03 | 1.26 | 25.86% | -9.15% |
4.3%
-1.0%
0.1%
9.0%
58.1%
24.6%
0%
Y-axis is the maximum loss one would have experienced if CVS Health was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 2.5% | 339,204 | 330,919 | 322,467 | 315,225 | 307,860 | 299,840 | 292,111 | 285,061 | 278,323 | 271,048 | 268,706 | 266,041 | 263,795 | 261,885 | 256,776 | 244,311 | 226,991 | 210,482 | 194,579 | 188,546 | 187,242 |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 29,292 | 29,081 |
Operating Expenses | - | - | - | - | - | 38,094 | 37,490 | - | - | 35,016 | 34,748 | - | 34,356 | 34,480 | 33,854 | 33,541 | 31,500 | 27,880 | 24,705 | 21,368 | 19,332 | 18,984 |
EBITDA | -100.0% | - | 12,235 | 12,347 | 10,745 | 17,460 | 17,269 | 17,435 | 14,277 | 14,047 | 14,366 | 14,211 | 15,205 | 15,526 | 13,362 | 13,368 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.04* | 0.04* | 0.03* | 0.06* | 0.06* | 0.06* | 0.05* | 0.05* | 0.05* | 0.05* | 0.06* | 0.06* | 0.05* | 0.05* | - | - | - | - | - | - |
Interest Expenses | 4.5% | 2,393 | 2,290 | 2,287 | 2,343 | 2,379 | 2,432 | 2,503 | 2,573 | 2,702 | 2,831 | 2,907 | 2,963 | 2,979 | 2,986 | 3,035 | 3,034 | 2,961 | 2,878 | 2,619 | 3,692 | 2,773 |
Earnings Before Taxes | -26.6% | 4,310 | 5,869 | 5,836 | 4,361 | 10,962 | 10,568 | 10,537 | 10,075 | 9,736 | 9,961 | 9,770 | 10,879 | 11,206 | 9,837 | 8,997 | 6,765 | 6,531 | 1,875 | 1,406 | 4,113 | 4,276 |
EBT Margin | -100.0% | - | 0.02* | 0.02* | 0.01* | 0.03* | 0.03* | 0.04* | 0.04* | 0.03* | 0.04* | 0.04* | 0.04* | 0.04* | 0.04* | 0.04* | - | - | - | - | - | - |
Net Income | -26.7% | 3,091 | 4,219 | 4,311 | 3,365 | 8,379 | 8,141 | 8,001 | 7,586 | 7,212 | 7,407 | 7,179 | 7,969 | 8,275 | 7,225 | 6,634 | 4,468 | 4,328 | -171 | -594 | 3,112 | 3,007 |
Net Income Margin | -100.0% | - | 0.01* | 0.01* | 0.01* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 17,392 | 13,450 | 19,498 | 15,868 | 16,194 | 15,745 | 15,191 | 11,618 | 12,928 | 13,428 | 12,641 | 13,628 | 11,722 | 10,391 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 4.5% | 250,071 | 239,330 | 228,275 | 231,212 | 230,279 | 232,873 | 233,052 | 234,891 | 231,164 | 229,606 | 230,715 | 232,898 | 235,495 | 230,639 | 222,449 | 220,113 | 218,904 | 219,768 | 196,456 | 131,506 | 133,290 |
Current Assets | -1.4% | 67,756 | 68,706 | 65,633 | 68,341 | 62,142 | 61,483 | 60,035 | 60,842 | 56,559 | 55,719 | 56,369 | 59,211 | 62,506 | 58,958 | 50,302 | 48,185 | 46,901 | 47,857 | 45,243 | 71,981 | 73,790 |
Cash Equivalents | -5.5% | 13,807 | 14,618 | 12,945 | 17,197 | 12,463 | 11,611 | 12,691 | 9,826 | 7,119 | 5,598 | 7,854 | 9,532 | 15,145 | 10,337 | 8,408 | 5,469 | 6,338 | 6,168 | 6,553 | 41,827 | 44,057 |
Inventory | -5.3% | 17,291 | 18,263 | 19,090 | 18,058 | 17,375 | 18,160 | 17,760 | 17,399 | 16,979 | 17,618 | 18,496 | 17,478 | 16,519 | 16,976 | 17,516 | 16,028 | 15,511 | 15,448 | 16,450 | 14,818 | 14,922 |
Net PPE | 1.0% | 13,001 | 12,872 | 12,873 | 12,626 | 12,764 | 12,844 | 12,896 | 12,771 | 12,664 | 12,611 | 12,606 | 12,349 | 12,221 | 12,146 | 12,044 | 11,651 | 11,483 | 11,348 | 11,349 | 10,419 | 10,249 |
Goodwill | 1442.3% | 91,260 | 5,917 | 78,150 | 78,086 | 78,560 | 79,060 | 79,121 | 79,121 | 79,552 | 79,552 | 79,552 | 79,579 | 80,057 | 79,993 | 79,749 | 79,548 | 79,485 | 79,075 | 78,678 | 34,216 | 34,220 |
Liabilities | 5.6% | 177,069 | 167,750 | 156,506 | 160,201 | 154,773 | 158,733 | 158,211 | 160,273 | 157,599 | 158,442 | 161,014 | 163,786 | 167,140 | 165,165 | 158,279 | 157,180 | 157,305 | 159,762 | 137,913 | 94,884 | 97,679 |
Current Liabilities | 5.5% | 79,206 | 75,054 | 69,421 | 72,409 | 68,457 | 69,780 | 67,719 | 64,709 | 59,311 | 60,104 | 62,017 | 62,044 | 63,694 | 59,560 | 53,303 | 52,544 | 49,376 | 50,631 | 45,762 | 29,460 | 31,493 |
Short Term Borrowings | - | 1,000 | - | - | - | - | - | - | - | - | 252 | - | - | - | 255 | - | 1,070 | 446 | 3,005 | 720 | - | - |
Long Term Debt | 8.8% | 61,419 | 56,450 | 50,476 | 50,848 | 50,797 | 52,063 | 51,971 | 56,832 | 59,294 | 59,270 | 59,207 | 61,552 | - | - | 64,699 | - | - | - | 71,444 | - | - |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,192 | 5,828 | 3,781 | 3,778 | 3,894 | 3,893 | 1,265 | 2,139 | 3,540 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | 63,481 | 65,735 | 64,699 | 64,206 | 66,941 | 67,888 | 71,444 | 60,747 | 61,569 |
Shareholder's Equity | 1.6% | 72,726 | 71,580 | 71,469 | 70,683 | 75,736 | 74,034 | 75,381 | 74,618 | 73,565 | 71,164 | 69,701 | 69,112 | 68,355 | 65,474 | 64,170 | 62,933 | 61,599 | 60,006 | 58,543 | 36,622 | 35,611 |
Retained Earnings | 1.9% | 58,868 | 57,753 | 56,398 | 54,571 | 58,710 | 56,488 | 54,997 | 54,264 | 53,331 | 51,203 | 49,640 | 49,328 | 48,768 | 46,455 | 45,108 | 44,017 | 43,136 | 41,859 | 40,911 | 41,843 | 40,965 |
Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 32,360 | 32,264 |
Shares Outstanding | 0.2% | 1,282 | 1,279 | 1,300 | 1,315 | 1,313 | 1,312 | 1,322 | 1,321 | 1,319 | 1,313 | 1,310 | 1,310 | 1,309 | 1,306 | 1,302 | 1,302 | 1,301 | 1,298 | 1,295 | 1,020 | 1,018 |
Minority Interest | 39.4% | 276 | 198 | 300 | 328 | 322 | 310 | 306 | 310 | 321 | 314 | 312 | 305 | 333 | 334 | 306 | 319 | 317 | 320 | 318 | 4.00 | 4.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 2.3% | 20,517 | 20,052 | 16,177 | 22,134 | 18,532 | 18,936 | 18,265 | 17,827 | 14,180 | 15,452 | 15,865 | 14,932 | 15,986 | 14,205 | 12,848 | 12,693 | 10,862 | 8,458 | 8,865 | 6,250 | 7,764 |
Share Based Compensation | 12.4% | 518 | 461 | 447 | 479 | 488 | 486 | 484 | 458 | 453 | 391 | 400 | 386 | 406 | 435 | 453 | 463 | 396 | 339 | 280 | 233 | 236 |
Cashflow From Investing | -71.2% | -19,800 | -11,568 | -5,047 | -6,368 | -6,410 | -5,387 | -5,261 | -5,055 | -5,578 | -5,804 | -5,534 | -5,009 | -4,468 | -4,045 | -3,339 | -44,529 | -44,334 | -44,045 | -43,285 | -2,696 | -2,495 |
Cashflow From Financing | 118.4% | 947 | -5,140 | -10,516 | -11,243 | -9,955 | -10,821 | -11,356 | -11,718 | -15,905 | -13,556 | -7,696 | -5,664 | -2,515 | -5,795 | -7,654 | -4,518 | -4,243 | -505 | 36,819 | 35,597 | 36,504 |
Dividend Payments | 1.9% | 3,019 | 2,964 | 2,907 | 2,848 | 2,781 | 2,691 | 2,625 | 2,609 | 2,615 | 2,628 | 2,624 | 2,631 | 2,612 | 2,606 | 2,603 | 2,462 | 2,326 | 2,179 | 2,038 | 2,038 | 2,039 |
Buy Backs | -0.1% | 3,516 | 3,518 | 3,500 | 2,000 | 2,000 | 2,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues: | ||||
Premiums | $ 25,108 | $ 21,260 | $ 49,460 | $ 42,891 |
Net investment income | 274 | 146 | 608 | 314 |
Total revenues | 88,921 | 80,636 | 174,199 | 157,462 |
Operating costs: | ||||
Cost of products sold | 53,536 | 49,290 | 104,991 | 94,799 |
Health care costs | 21,782 | 17,490 | 42,230 | 35,413 |
Restructuring charge | 496 | 0 | 496 | 0 |
Opioid litigation charge | 0 | 0 | 0 | 484 |
Loss on assets held for sale | 0 | 0 | 349 | 41 |
Operating expenses | 9,873 | 9,187 | 19,453 | 18,511 |
Total operating costs | 85,687 | 75,967 | 167,519 | 149,248 |
Operating income | 3,234 | 4,669 | 6,680 | 8,214 |
Interest expense | 686 | 583 | 1,275 | 1,169 |
Other income | (22) | (43) | (44) | (85) |
Income before income tax provision | 2,570 | 4,129 | 5,449 | 7,130 |
Income tax provision | 656 | 1,090 | 1,393 | 1,736 |
Net income | 1,914 | 3,039 | 4,056 | 5,394 |
Net income attributable to noncontrolling interests | (13) | (10) | (19) | (11) |
Net income attributable to CVS Health | $ 1,901 | $ 3,029 | $ 4,037 | $ 5,383 |
Net income per share attributable to CVS Health: | ||||
Basic (in dollars per share) | $ 1.48 | $ 2.31 | $ 3.15 | $ 4.10 |
Diluted (in dollars per share) | $ 1.48 | $ 2.29 | $ 3.13 | $ 4.06 |
Weighted average shares outstanding: | ||||
Basic (in shares) | 1,283 | 1,313 | 1,283 | 1,312 |
Diluted (in shares) | 1,287 | 1,321 | 1,289 | 1,325 |
Dividends declared per share (in dollars per share) | $ 0.605 | $ 0.55 | $ 1.21 | $ 1.10 |
Cost, Product and Service [Extensible List] | Products | Products | Products | Products |
Products | ||||
Revenues: | ||||
Revenues | $ 60,539 | $ 56,794 | $ 118,686 | $ 109,316 |
Services | ||||
Revenues: | ||||
Revenues | $ 3,000 | $ 2,436 | $ 5,445 | $ 4,941 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Assets: | ||
Cash and cash equivalents | $ 13,807 | $ 12,945 |
Investments | 3,080 | 2,778 |
Accounts receivable, net | 29,546 | 27,276 |
Inventories | 17,291 | 19,090 |
Assets held for sale | 620 | 908 |
Other current assets | 3,412 | 2,636 |
Total current assets | 67,756 | 65,633 |
Long-term investments | 22,114 | 21,096 |
Property and equipment, net | 13,001 | 12,873 |
Operating lease right-of-use assets | 17,703 | 17,872 |
Goodwill | 91,260 | 78,150 |
Intangible assets, net | 30,118 | 24,803 |
Separate accounts assets | 3,267 | 3,228 |
Other assets | 4,852 | 4,620 |
Total assets | 250,071 | 228,275 |
Liabilities: | ||
Accounts payable | 13,367 | 14,838 |
Pharmacy claims and discounts payable | 20,417 | 19,423 |
Health care costs payable | 11,998 | 10,142 |
Policyholders’ funds | 1,411 | 1,500 |
Accrued expenses | 22,831 | 18,745 |
Other insurance liabilities | 4,866 | 1,089 |
Current portion of operating lease liabilities | 1,706 | 1,678 |
Short-term debt | 1,000 | 0 |
Current portion of long-term debt | 1,402 | 1,778 |
Liabilities held for sale | 208 | 228 |
Total current liabilities | 79,206 | 69,421 |
Long-term operating lease liabilities | 16,609 | 16,800 |
Long-term debt | 61,419 | 50,476 |
Deferred income taxes | 4,588 | 4,016 |
Separate accounts liabilities | 3,267 | 3,228 |
Other long-term insurance liabilities | 5,659 | 5,835 |
Other long-term liabilities | 6,321 | 6,730 |
Total liabilities | 177,069 | 156,506 |
Shareholders’ equity: | ||
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | 0 | 0 |
Common stock, par value $0.01: 3,200 shares authorized; 1,764 shares issued and 1,282 shares outstanding at June 30, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus | 48,649 | 48,193 |
Treasury stock, at cost: 482 shares at June 30, 2023 and 458 shares at December 31, 2022 | (33,933) | (31,858) |
Retained earnings | 58,868 | 56,398 |
Accumulated other comprehensive loss | (858) | (1,264) |
Total CVS Health shareholders’ equity | 72,726 | 71,469 |
Noncontrolling interests | 276 | 300 |
Total shareholders’ equity | 73,002 | 71,769 |
Total liabilities and shareholders’ equity | $ 250,071 | $ 228,275 |